December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

The Oncology Institute, Inc. - Warrant (NQ:TOIIW)

0.1100 +0.0045 (+4.27%)
Streaming Delayed Price Updated: 3:10 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about The Oncology Institute, Inc. - Warrant

< Previous 1 2 3 Next >
The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference
From TOI Management, LLC
Via GlobeNewswire
The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care
From TOI Management, LLC
Via GlobeNewswire
The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation
Practice earns maximum quality points on avoidable ED visits and admissions, saving more than $3,500 per episode 
From TOI Management, LLC
Via GlobeNewswire
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos
From TOI Management, LLC
Via GlobeNewswire
The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida
From TOI Management, LLC
Via GlobeNewswire
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Changes to Board of Directors
Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman 
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Names Kristin England as Chief Administrative Officer
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
From Toi Management, LLC
Via GlobeNewswire
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces $16.5 million Private Placement
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown
From Toi Management, LLC
Via GlobeNewswire
Florida Blue enhances cancer care for thousands of members
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care 
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Reports Third Quarter 2024 Financial Results
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California
TOI will be one of the few community-based practices on the West Coast to offer radiopharmaceuticals in the outpatient setting. 
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence
From Toi Management, LLC
Via GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute of Hope & Innovation Launches Oregon Market
Anchor value-based payor partnership leads to opening of locations in Portland and Salem 
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces CFO Transition
Rob Carter promoted to Chief Financial Officer 
From Toi Management, LLC
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.